Investors demand more
New research from Barclays Stockbrokers reveals that more than one in ten investors currently use Level 2 pricing and a further 33 per cent use Direct Market Access (DMA), both of which have only recently been made available widely to private investors.
Level 1 pricing enables investors to see the bid, offer and the day’s high and low prices of specific stocks in real time, as opposed to the delayed pricing information which is traditionally used by retail brokers.
Level 2 is a more recent phenomenon and allows investors to view the order book – the actual buy and sell orders for each share in the market as they are entered, amended and executed in real time. This in turn shows what is known as ‘market depth’ – the buying and selling for a particular share.
DMA enables private investors to react to this market depth, allowing them to place buy or sell orders directly on the London Stock Exchange (LSE) order book.
Barclays Stockbrokers offers access to Level 1 and 2 equity trading through its BARX platform. Stephen Grady, head of global dealing at Barclays Wealth, comments: ‘We have seen a real shift in recent years in terms of the techniques and products that our clients are using to gain returns.’
According to the LSE, the use of Level 2 data is growing at a frenetic pace, with a 400 per cent increase in usage in the last 18 months.
Martin Graham, director of markets at the LSE, explains: ‘There has been a huge expansion in trading volumes on our books recently, with the total number of trades per day now running at an average of 573,767, an increase of more than 70 per cent.
‘Private investors are able to gain a complete picture of the vast liquidity pool that generates these trades through Level 2 data and use this information to inform the pricing and timing of their trades.’
Advertisement
Latest news
US equities back in favour 2 December 2008
In a turnaround from this time last year, the USA is now the preferred global equity market, according to JP Morgan.
- The rise of the ‘instividual’ investor 4 November 2008
- Investment opportunities in US equities 31 October 2008
- Pound could reach historic lows 30 October 2008
Recommendations
Top 10 Inv Trusts, 1yr%
| Prospect Japan Li... | +40.2 | ||
| Genesis Malaysia Maju | +31.7 | ||
| JP Morgan Private... | +25.9 | ||
| Ruffer Investment... | +10.5 | ||
| Smaller Companies... | +8.1 | ||
| Investec High Inc... | +6.7 | ||
| Ecofin Water & Po... | +6.7 | ||
| Jupiter Second Sp... | +6.3 | ||
| JP Morgan Income ... | +5.9 | ||
| JZ Capital Partners | +5.7 | ||
Share dealing in depth
Market adjustments 12 November 2008
Robert Tyerman assesses how global markets will adjust to a new set of financial rules
- Youthful enthusiasm 6 November 2008
- Bear necessities 2 September 2008
- Instant investment 5 August 2008
Guides
Silver lining at AMS 19 November 2008
Wound treatment developer Advanced Medical Solutions (AMS) has seen its share price
triple in three years – but new investors shouldn’t think they’ve missed the boat as there should be plenty more to come. Oliver Haill reports
- Driving in a higher gear 22 October 2008
- Let the market do the work 3 October 2008
- Calculating the odds 30 September 2008
Special Offers
- 2008 AIM Guide:
Essential information for anyone interested in the
Alternative Investment Market. - Growth Company Investor Magazine:
1 month no obligation free trial providing independent,
timely and thoroughly researched recommendations on
high potential smaller companies. - Venture Capital Trusts
Venture Capital Trusts (VCTs) currently have over
£1 billion to invest in young, growing companies. - Annual report service
Free access to annual reports and other information
on selected companies


